Teleflex Inc (TFX)
209.07
+2.43
(+1.18%)
USD |
NYSE |
May 31, 16:00
209.13
+0.06
(+0.03%)
After-Hours: 20:00
Teleflex SG&A Expense (Quarterly): 380.97M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 380.97M |
December 31, 2023 | 260.65M |
September 30, 2023 | 213.19M |
June 30, 2023 | 223.31M |
March 31, 2023 | 232.72M |
December 31, 2022 | 233.38M |
September 30, 2022 | 209.62M |
June 30, 2022 | 216.82M |
March 31, 2022 | 203.93M |
December 31, 2021 | 227.58M |
September 30, 2021 | 205.19M |
June 30, 2021 | 224.16M |
March 31, 2021 | 203.15M |
December 31, 2020 | 232.91M |
September 30, 2020 | 171.67M |
June 30, 2020 | 191.19M |
March 31, 2020 | 147.80M |
December 31, 2019 | 220.05M |
September 30, 2019 | 209.29M |
June 30, 2019 | 215.50M |
March 31, 2019 | 206.92M |
December 31, 2018 | 136.91M |
September 30, 2018 | 214.89M |
June 30, 2018 | 229.92M |
March 31, 2018 | 215.34M |
Date | Value |
---|---|
December 31, 2017 | 213.29M |
September 30, 2017 | 163.77M |
June 30, 2017 | 158.93M |
March 31, 2017 | 163.97M |
December 31, 2016 | 144.18M |
September 30, 2016 | 139.80M |
June 30, 2016 | 142.98M |
March 31, 2016 | 136.35M |
December 31, 2015 | 148.22M |
September 30, 2015 | 138.84M |
June 30, 2015 | 142.23M |
March 31, 2015 | 139.70M |
December 31, 2014 | 153.26M |
September 30, 2014 | 138.25M |
June 30, 2014 | 146.84M |
March 31, 2014 | 140.30M |
December 31, 2013 | 143.76M |
September 30, 2013 | 115.23M |
June 30, 2013 | 116.25M |
March 31, 2013 | 126.95M |
December 31, 2012 | 121.52M |
September 30, 2012 | 114.88M |
June 30, 2012 | 105.95M |
March 31, 2012 | 112.14M |
December 31, 2011 | 110.78M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
147.80M
Minimum
Mar 2020
380.97M
Maximum
Mar 2024
221.15M
Average
216.16M
Median
SG&A Expense (Quarterly) Benchmarks
ResMed Inc | 229.92M |
Stryker Corp | 1.84B |
Boston Scientific Corp | 1.364B |
Perspective Therapeutics Inc | 5.878M |
Xtant Medical Holdings Inc | 20.24M |